Latest Fund Restructuring News

JPMorgan US 100Q Equity Premium Income ETF lifted operating profit to A$15.678 million as net assets grew to A$106.991 million. The fund is now preparing to move its underlying investment from a Nasdaq-listed ETF to a London-listed UCITS vehicle, with total management fees and costs unchanged at 0.40% a year.

Minbos Resources advances its Cabinda phosphate fertilizer project with key funding restructures, minority shareholder buyouts, and the start of early mining operations. Strategic partnerships and construction milestones position the company for growth despite funding delays.

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

DigitalX Limited posted a larger loss for FY25 despite an 18% revenue increase, driven by digital asset appreciation and a bold Bitcoin accumulation strategy.

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.